Superantigenic activity produced by group A streptococcal isolates is neutralized by plasma from IVIG-treated streptococcal toxic shock syndrome patients

Adv Exp Med Biol. 1997:418:563-6. doi: 10.1007/978-1-4899-1825-3_130.
No abstract available

MeSH terms

  • Antibodies, Bacterial / blood
  • Bacterial Proteins*
  • Exotoxins / toxicity
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use*
  • In Vitro Techniques
  • Interferon-gamma / biosynthesis
  • Lymphotoxin-alpha / biosynthesis
  • Membrane Proteins*
  • Neutralization Tests
  • Shock, Septic / immunology*
  • Shock, Septic / therapy*
  • Streptococcal Infections / immunology*
  • Streptococcal Infections / therapy*
  • Streptococcus pyogenes / immunology*
  • Streptococcus pyogenes / isolation & purification
  • Streptococcus pyogenes / pathogenicity
  • Superantigens / biosynthesis*

Substances

  • Antibodies, Bacterial
  • Bacterial Proteins
  • Exotoxins
  • Immunoglobulins, Intravenous
  • Lymphotoxin-alpha
  • Membrane Proteins
  • SpeA protein, Streptococcus pyogenes
  • Superantigens
  • erythrogenic toxin
  • Interferon-gamma